GlassScriptPhysician profile
Joe K Ades
NPI 1073750683
$4,092.59
in general payments reported to CMS, 2019-2025
30 companies · $1,176 in 2025
The $1,176 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.60 · 2020: $240 · 2021: $487 · 2022: $435 · 2023: $435 · 2024: $1,260 · 2025: $1,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,871.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $543.44 | 2023-2024 | |
| Smith+Nephew, INC. | $499.97 | 2019-2025 | Stravix, Grafix Pl, Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $383.13 | 2022-2025 | Augment Injectable, 7 X 23mm Citrelock Implant, Prostep |
| Peerless Surgical INC. | $373.27 | 2021-2025 | |
| Treace Medical Concepts, INC. | $370.26 | 2023-2025 | |
| Organogenesis INC. | $365.14 | 2020-2025 | Cygnus Dual |
| Depuy Synthes Sales INC. | $336.15 | 2024-2025 | Motoband, N/A, Na |
| Integra Lifesciences Corporation | $138.56 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $118.58 | 2022-2025 | Nuzyra |
| Paragon 28, INC. | $116.70 | 2024 | Mtp |
| Abbvie INC. | $98.94 | 2023 | Dalvance |
| Voom Medical Devices, INC. | $81.66 | 2025 | Revcon |
| Trimed, INC. | $73.78 | 2021 | |
| Bioventus LLC | $69.17 | 2020-2021 | |
| Nevro Corp. | $65.14 | 2022-2024 | Senza |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $57.02 | 2024-2025 | Krystexxa |
| Kci USA, INC. | $42.24 | 2020 | |
| Globus Medical, INC. | $42.16 | 2025 | Omnia |
| Orthofix Medical, INC. | $40.99 | 2024 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $37.64 | 2020 | |
| Sebela Pharmaceuticals INC. | $35.07 | 2019-2022 | |
| Nabriva Therapeutics, Plc | $32.17 | 2022 | |
| Polarityte, INC. | $29.39 | 2019 | |
| Tactile Systems Technology INC | $29.19 | 2022 | |
| Carbofix Orthopedics INC | $21.87 | 2021 | |
| Kerecis Limited | $21.85 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Grt US Holding, INC. | $21.65 | 2021 | |
| Allergan, INC. | $18.13 | 2020 | |
| Medtronic, INC. | $15.67 | 2023 | Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $13.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Ades listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.